Alopecia - Pipeline Review, H1 2017
ReportsWeb.com has announced the addition of the “Alopecia - Pipeline Review, H1 2017” this report provides an overview of the Alopecia (Dermatology) pipeline landscape.
(EMAILWIRE.COM, June 10, 2017 ) Alopecia is the partial or complete loss of hair especially on the scalp either in patches, on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, irritants, toxins, burns, injuries, and infections.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Alopecia - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Alopecia (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 15, 4, 1, 18 and 8 respectively. Similarly, the Universities portfolio in Phase III and Discovery stages comprises 1 and 1 molecules, respectively.
Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For more information about this report at http://www.reportsweb.com/alopecia-pipeline-review-h1-2017
Report Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology).
- The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001689407/sample
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Key Company profiles
Aclaris Therapeutics Inc
Allergan Plc
Almirall SA
AndroScience Corp
Berg LLC
BiologicsMD Inc
BirchBioMed Inc
Bristol-Myers Squibb Company
Cassiopea SpA
Concert Pharmaceuticals Inc
Dong-A Socio Holdings Co Ltd
Follicum AB
Handok Inc
Histogen Inc
Hyundai Pharmaceutical Co Ltd
Incyte Corp
Kuhnil Pharmaceutical Co Ltd
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Medivir AB
NovaLead Pharma Pvt Ltd
Novartis AG
Panacea Biotec Ltd
Pfizer Inc
Quark Pharmaceuticals Inc
RiverTown Therapeutics Inc
RXi Pharmaceuticals Corp
Samumed LLC
SWITCH Biotech LLC
Taisho Pharmaceutical Holdings Co Ltd
Tigo GmbH
viDA Therapeutics Inc
Ask for Discount at http://www.reportsweb.com/inquiry&RW0001689408/discount
List of Tables
Number of Products under Development for Alopecia, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Alopecia - Pipeline by Aclaris Therapeutics Inc, H1 2017
Alopecia - Pipeline by Allergan Plc, H1 2017
Alopecia - Pipeline by Almirall SA, H1 2017
Alopecia - Pipeline by AndroScience Corp, H1 2017
Alopecia - Pipeline by Berg LLC, H1 2017
Alopecia - Pipeline by BiologicsMD Inc, H1 2017
Alopecia - Pipeline by BirchBioMed Inc, H1 2017
Alopecia - Pipeline by Bristol-Myers Squibb Company, H1 2017
Alopecia - Pipeline by Cassiopea SpA, H1 2017
Alopecia - Pipeline by Concert Pharmaceuticals Inc, H1 2017
Alopecia - Pipeline by Dong-A Socio Holdings Co Ltd, H1 2017
Alopecia - Pipeline by Follicum AB, H1 2017
Alopecia - Pipeline by Handok Inc, H1 2017
Alopecia - Pipeline by Histogen Inc, H1 2017
Alopecia - Pipeline by Hyundai Pharmaceutical Co Ltd, H1 2017
Alopecia - Pipeline by Incyte Corp, H1 2017
Alopecia - Pipeline by Kuhnil Pharmaceutical Co Ltd, H1 2017
Alopecia - Pipeline by Lee's Pharmaceutical Holdings Ltd, H1 2017
Alopecia - Pipeline by LEO Pharma A/S, H1 2017
Alopecia - Pipeline by Medivir AB, H1 2017
Alopecia - Pipeline by NovaLead Pharma Pvt Ltd, H1 2017
Alopecia - Pipeline by Novartis AG, H1 2017
Alopecia - Pipeline by Panacea Biotec Ltd, H1 2017
Alopecia - Pipeline by Pfizer Inc, H1 2017
Alopecia - Pipeline by Quark Pharmaceuticals Inc, H1 2017
Alopecia - Pipeline by RiverTown Therapeutics Inc, H1 2017
Alopecia - Pipeline by RXi Pharmaceuticals Corp, H1 2017
Alopecia - Pipeline by Samumed LLC, H1 2017
Alopecia - Pipeline by SWITCH Biotech LLC, H1 2017
Alopecia - Pipeline by Taisho Pharmaceutical Holdings Co Ltd, H1 2017
Alopecia - Pipeline by Tigo GmbH, H1 2017
Alopecia - Pipeline by viDA Therapeutics Inc, H1 2017
Alopecia - Dormant Projects, H1 2017
Alopecia - Dormant Projects, H1 2017 (Contd..1), H1 2017
Alopecia - Discontinued Products, H1 2017
Purchase Complete Report at http://www.reportsweb.com/buy&RW0001689408/buy/2000
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Alopecia - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Alopecia (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 15, 4, 1, 18 and 8 respectively. Similarly, the Universities portfolio in Phase III and Discovery stages comprises 1 and 1 molecules, respectively.
Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For more information about this report at http://www.reportsweb.com/alopecia-pipeline-review-h1-2017
Report Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology).
- The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001689407/sample
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Key Company profiles
Aclaris Therapeutics Inc
Allergan Plc
Almirall SA
AndroScience Corp
Berg LLC
BiologicsMD Inc
BirchBioMed Inc
Bristol-Myers Squibb Company
Cassiopea SpA
Concert Pharmaceuticals Inc
Dong-A Socio Holdings Co Ltd
Follicum AB
Handok Inc
Histogen Inc
Hyundai Pharmaceutical Co Ltd
Incyte Corp
Kuhnil Pharmaceutical Co Ltd
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Medivir AB
NovaLead Pharma Pvt Ltd
Novartis AG
Panacea Biotec Ltd
Pfizer Inc
Quark Pharmaceuticals Inc
RiverTown Therapeutics Inc
RXi Pharmaceuticals Corp
Samumed LLC
SWITCH Biotech LLC
Taisho Pharmaceutical Holdings Co Ltd
Tigo GmbH
viDA Therapeutics Inc
Ask for Discount at http://www.reportsweb.com/inquiry&RW0001689408/discount
List of Tables
Number of Products under Development for Alopecia, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Alopecia - Pipeline by Aclaris Therapeutics Inc, H1 2017
Alopecia - Pipeline by Allergan Plc, H1 2017
Alopecia - Pipeline by Almirall SA, H1 2017
Alopecia - Pipeline by AndroScience Corp, H1 2017
Alopecia - Pipeline by Berg LLC, H1 2017
Alopecia - Pipeline by BiologicsMD Inc, H1 2017
Alopecia - Pipeline by BirchBioMed Inc, H1 2017
Alopecia - Pipeline by Bristol-Myers Squibb Company, H1 2017
Alopecia - Pipeline by Cassiopea SpA, H1 2017
Alopecia - Pipeline by Concert Pharmaceuticals Inc, H1 2017
Alopecia - Pipeline by Dong-A Socio Holdings Co Ltd, H1 2017
Alopecia - Pipeline by Follicum AB, H1 2017
Alopecia - Pipeline by Handok Inc, H1 2017
Alopecia - Pipeline by Histogen Inc, H1 2017
Alopecia - Pipeline by Hyundai Pharmaceutical Co Ltd, H1 2017
Alopecia - Pipeline by Incyte Corp, H1 2017
Alopecia - Pipeline by Kuhnil Pharmaceutical Co Ltd, H1 2017
Alopecia - Pipeline by Lee's Pharmaceutical Holdings Ltd, H1 2017
Alopecia - Pipeline by LEO Pharma A/S, H1 2017
Alopecia - Pipeline by Medivir AB, H1 2017
Alopecia - Pipeline by NovaLead Pharma Pvt Ltd, H1 2017
Alopecia - Pipeline by Novartis AG, H1 2017
Alopecia - Pipeline by Panacea Biotec Ltd, H1 2017
Alopecia - Pipeline by Pfizer Inc, H1 2017
Alopecia - Pipeline by Quark Pharmaceuticals Inc, H1 2017
Alopecia - Pipeline by RiverTown Therapeutics Inc, H1 2017
Alopecia - Pipeline by RXi Pharmaceuticals Corp, H1 2017
Alopecia - Pipeline by Samumed LLC, H1 2017
Alopecia - Pipeline by SWITCH Biotech LLC, H1 2017
Alopecia - Pipeline by Taisho Pharmaceutical Holdings Co Ltd, H1 2017
Alopecia - Pipeline by Tigo GmbH, H1 2017
Alopecia - Pipeline by viDA Therapeutics Inc, H1 2017
Alopecia - Dormant Projects, H1 2017
Alopecia - Dormant Projects, H1 2017 (Contd..1), H1 2017
Alopecia - Discontinued Products, H1 2017
Purchase Complete Report at http://www.reportsweb.com/buy&RW0001689408/buy/2000
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results